open access

Vol 89, No 5 (2021)
Letter to the Editor
Submitted: 2021-05-05
Accepted: 2021-06-26
Published online: 2021-10-06
Get Citation

High-dose steroids for the treatment of severe COVID-19 pneumonia: the need of the hour?

Abhishek Tandon1, Vedansh Chandra2
DOI: 10.5603/ARM.a2021.0084
·
Pubmed: 34612506
·
Adv Respir Med 2021;89(5):550-551.
Affiliations
  1. Department of Pulmonary, Critical Care and Sleep Medicine, All India Institute of Medical Sciences, Jodhpur, India
  2. Department of Internal Medicine, University of Maryland Capital Region Health, Maryland, USA, Maryland, United States

open access

Vol 89, No 5 (2021)
LETTERS
Submitted: 2021-05-05
Accepted: 2021-06-26
Published online: 2021-10-06

Abstract

Not available

Abstract

Not available
Get Citation

Keywords

steroids; COVID-19 pneumonia

About this article
Title

High-dose steroids for the treatment of severe COVID-19 pneumonia: the need of the hour?

Journal

Advances in Respiratory Medicine

Issue

Vol 89, No 5 (2021)

Article type

Letter to the Editor

Pages

550-551

Published online

2021-10-06

DOI

10.5603/ARM.a2021.0084

Pubmed

34612506

Bibliographic record

Adv Respir Med 2021;89(5):550-551.

Keywords

steroids
COVID-19 pneumonia

Authors

Abhishek Tandon
Vedansh Chandra

References (5)
  1. Horby P, Lim WS, Emberson JR, et al. RECOVERY Collaborative Group. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 2021; 384(8): 693–704.
  2. Edara L, Suvvari TK, Kutikuppala LV. High dose steroid therapy to prevent severe hypoxia in COVID-19 patients: A potential solution for low resource clinical setting. Cureus. 2020; 12(12): e12330.
  3. So C, Ro S, Murakami M, et al. High-dose, short-term corticosteroids for ARDS caused by COVID-19: a case series. Respirol Case Rep. 2020; 8(6): e00596.
  4. Edalatifard M, Akhtari M, Salehi M, et al. Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial. Eur Respir J. 2020; 56(6).
  5. López Zúñiga MÁ, Moreno-Moral A, Ocaña-Granados A, et al. High-dose corticosteroid pulse therapy increases the survival rate in COVID-19 patients at risk of hyper-inflammatory response. PLoS One. 2021; 16(1): e0243964.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Pneumonologia i Alergologia Polska dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl